Literature DB >> 3415404

Clinical predictors of electrophysiologic findings in patients with syncope of unknown origin.

P Denes1, E Uretz, M D Ezri, J Borbola.   

Abstract

Unexplained syncope is a common medical problem. Intracardiac electrophysiologic studies (EPS) have been used to uncover the underlying arrhythmic mechanisms. Electrophysiologic studies are especially helpful in the management of patients with inducible tachyarrhythmias, but is of limited usefulness in those with normal EPS findings. We investigated whether clinical and noninvasive laboratory variables can predict the results of EPS in 89 patients with unexplained syncope. The prevalence of inducible ventricular tachycardia (VT) was 15%; supraventricular tachycardia, 15%; bradyarrhythmias, 41%; and normal EPS, 29%. We used multivariate discriminant function analysis to predict the results of EPS. The variables selected for identification of patients with inducible VT by this analysis include New York Heart Association (NYHA) functional class, gender, digitalis use, nonsustained VT, and atrial fibrillation. Based on our statistical model, performing EPS on 45% of the patients with unexplained syncope would result in a 90% sensitivity in detecting patients with inducible VT. The variables selected for identification of patients with normal EPS findings include: New York Heart Association functional class, heart disease, digitalis use, and intraventricular conduction. Based on this model, it would require that all but 12% of patients with unexplained syncope be studied to achieve a 90% predictive accuracy for identification of patients with normal EPS. During follow-up, recurrence rates for the different EPS categories did not differ significantly. The five-year cumulative survival among the EPS groups were as follows: VT, 37% +/- 28%; SVT, 90% +/- 9%; bradyarrhythmias, 71% +/- 10%; and normal EPS, 96% +/- 4%. Survival of the VT group differed significantly from that of the normal group. In patients with unexplained syncope, EPS findings can be predicted from clinical and noninvasive laboratory data. Mortality during follow-up relates to EPS findings.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3415404

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  8 in total

1.  Implantable loop recorder: evaluation of unexplained syncope.

Authors:  R A Kenny; A D Krahn
Journal:  Heart       Date:  1999-04       Impact factor: 5.994

2.  Score indices for predicting electrophysiologic outcomes in patients with unexplained syncope.

Authors:  Lin Y Chen; Arshad Jahangir; Wyatt W Decker; Peter A Smars; Wouter Wieling; David O Hodge; Bernard J Gersh; Stephen C Hammill; Win-Kuang Shen
Journal:  J Interv Card Electrophysiol       Date:  2005-11       Impact factor: 1.900

3.  Standardized reporting guidelines for emergency department syncope risk-stratification research.

Authors:  Benjamin C Sun; Venkatesh Thiruganasambandamoorthy; Jeffrey Dela Cruz
Journal:  Acad Emerg Med       Date:  2012-06       Impact factor: 3.451

Review 4.  Collapse query cause: the management of adult syncope in the emergency department.

Authors:  M J Reed; A Gray
Journal:  Emerg Med J       Date:  2006-08       Impact factor: 2.740

5.  Predicting the outcomes of electrophysiologic studies of patients with unexplained syncope: preliminary validation of a derived model.

Authors:  M Linzer; E N Prystowsky; G W Divine; D B Matchar; G Samsa; F Harrell; J C Pressley; D B Pryor
Journal:  J Gen Intern Med       Date:  1991 Mar-Apr       Impact factor: 5.128

6.  Risk stratification of patients with syncope in an accident and emergency department.

Authors:  S D Crane
Journal:  Emerg Med J       Date:  2002-01       Impact factor: 2.740

7.  Predictors of 30-day serious events in older patients with syncope.

Authors:  Benjamin C Sun; Stephen F Derose; Li-Jung Liang; Gelareh Z Gabayan; Jerome R Hoffman; Alison A Moore; William R Mower; Carol M Mangione
Journal:  Ann Emerg Med       Date:  2009-09-19       Impact factor: 5.721

8.  Epidemiology of syncope in hospitalized patients.

Authors:  W S Getchell; G C Larsen; C D Morris; J H McAnulty
Journal:  J Gen Intern Med       Date:  1999-11       Impact factor: 5.128

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.